Abbott Laboratories Q2 Earnings Preview: Analysts Expect Growth Post Exact Sciences Acquisition

Analysts anticipate Abbott Laboratories (ABT) will report strong second-quarter earnings growth, driven by the acquisition of Exact Sciences. The firm is expected to release results on July 16 before market open.

By Nivedita Hazra, SA News Editor · Seeking Alpha · July 15, 2026, 15:45 UTC

Tickers: $ABT $EXAS

Topics: earnings healthcare

Read the full article at Seeking Alpha

More World news

Mercury Insurance Issues Safety Guidelines for Portable Generator Use During Power Outages PR Newswire · November 12, 2026, 14:06 UTC
Paratus Appoints New Senior Leadership to Drive Expansion into Asset-Backed Optimisation PR Newswire · November 12, 2026, 14:03 UTC
Transamerica Partners with Congruent Solutions to Modernize Retirement Plan Payroll Administration PR Newswire · November 12, 2026, 14:00 UTC
Kindo Raises $57.6 Million Total to Scale Enterprise AI Agent Management Platform PR Newswire · November 12, 2026, 14:00 UTC
Texans Credit Union Introduces Cash Back Checking and Ignite Youth Banking Suite PR Newswire · November 12, 2026, 14:03 UTC
Apple Announces Preorders for Select Smart Home Collection Accessories The Verge · November 12, 2026, 14:00 UTC
SolaREIT Surpasses $8.5 Billion Milestone in Clean Energy Land Financing PR Newswire · November 12, 2026, 14:00 UTC
Avalara Launches Native 1099 E-Filing Integration for Workday Financial Management PR Newswire · November 12, 2026, 14:00 UTC
Rocket Companies Appoints Datadog COO Adam Blitzer to Board of Directors PR Newswire · November 12, 2026, 14:00 UTC
ALKEME Insurance Announces 'ALKEME Bowl' Sponsorship of Arizona vs. Utah College Football Matchup PR Newswire · November 12, 2026, 14:00 UTC